- Filed
- Mar 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Feb 27, 2025 | 22.26M sh |
| Long Term Debt | Q2 2025 · Jan 31, 2025 | $471.47M |
| Long Term Debt | Q2 2025 · Aug 2, 2024 | $476.58M |
| Cash And Equivalents | Q2 2025 · Jan 31, 2025 | $10.35M |
| Cash And Equivalents | Q2 2025 · Aug 2, 2024 | $12.04M |
| Current Liabilities | Q2 2025 · Jan 31, 2025 | $454.24M |
| Current Liabilities | Q2 2025 · Aug 2, 2024 | $454.21M |
| Current Assets | Q2 2025 · Jan 31, 2025 | $280.26M |
| Current Assets | Q2 2025 · Aug 2, 2024 | $278.21M |
| Total Assets | Q2 2025 · Jan 31, 2025 | $2.15B |
| Total Assets | Q2 2025 · Aug 2, 2024 | $2.16B |
| Shares Diluted | Q2 2025 · Jan 26, 2024 | 22.3M sh |
| Shares Diluted | Q2 2025 · Jan 26, 2024 | 22.28M sh |
| Dividends Paid | Q2 2025 · Jan 26, 2024 | $58.34M |
| Capex | Q2 2025 · Jan 26, 2024 | $51.45M |
| Operating Cash Flow | Q2 2025 · Jan 26, 2024 | $61.88M |
| Stockholders Equity | Q2 2025 · Jan 26, 2024 | $461.97M |
| Stockholders Equity | Q2 2025 · Oct 27, 2023 | $460.25M |
| Stockholders Equity | Q2 2025 · Jul 28, 2023 | $483.83M |
| Eps Diluted | Q2 2025 · Jan 26, 2024 | $1.19 |
| Eps Diluted | Q2 2025 · Jan 26, 2024 | $1.44 |
| Eps Basic | Q2 2025 · Jan 26, 2024 | $1.20 |
| Eps Basic | Q2 2025 · Jan 26, 2024 | $1.44 |
| Sga Expense | Q2 2025 · Jan 26, 2024 | $52.54M |
| Sga Expense | Q2 2025 · Jan 26, 2024 | $101.27M |
| Net Income | Q2 2025 · Jan 26, 2024 | $26.53M |
| Net Income | Q2 2025 · Jan 26, 2024 | $31.99M |
| Net Income | Q2 2025 · Oct 27, 2023 | $5.46M |
| Operating Income | Q2 2025 · Jan 26, 2024 | $30.76M |
| Operating Income | Q2 2025 · Jan 26, 2024 | $42.18M |
| Cost Of Revenue | Q2 2025 · Jan 26, 2024 | $314.85M |
| Cost Of Revenue | Q2 2025 · Jan 26, 2024 | $570.41M |
| Revenue | Q2 2025 · Jan 26, 2024 | $935.4M |
| Revenue | Q2 2025 · Jan 26, 2024 | $1.76B |